ESR1 and breast carcinoma: The authors ruled out the contribution of ER activity on the basis that TRF (and therefore tocotrienols) did not affect the expression of a gene, the breast cancer estrogen inducible sequence-trefoil factor 1 (pS2-TFF1), known to be driven by estradiol due to the presence of an ERα responsive elements in its promoter.